Mirabegron is better tolerated than solifenacin in Sjogren's syndrome patients with overactive bladder symptoms—A randomized controlled trial

HX Chen, SH Chang, DY Chen, JL Lan… - LUTS: Lower Urinary …, 2023 - Wiley Online Library
Objectives This study investigates the efficacy and adverse events of beta‐3 agonists and
antimuscarinic agents for managing overactive bladder syndrome in Sjogren syndrome …

Effects of different urodynamic characteristics on therapeutic outcomes of overactive bladder medication in a real-life clinical practice

HJ Wang, HC Kuo - Tzu Chi Medical Journal, 2022 - journals.lww.com
Objective: This study retrospectively investigated the influence of urodynamic parameters
and patient characteristics on success rates among patients with overactive bladder (OAB) …

Hyperlipidemia as a risk factor for discontinuation of prescribed antimuscarinics among geriatric overactive bladder patients.

YC Chen, HW Chen, YS Juan - LUTS, 2019 - search.ebscohost.com
In our 10-year nationwide population-based cohort study in Taiwan,[5] up to 52.6% of OAB
patients using antimuscarinics for at least 3 months had concurrent hyperlipidemia, and …